IRE1 contributes to cancer cell survival and progression by promoting adaptation to hypoxia, nutrient deprivation, and oxidative stress. It also supports the maintenance of cancer stem cells, angiogenesis, and resistance to apoptosis. These features make IRE1 an attractive target for cancer therapy, as inhibiting its activity could impair the ability of cancer cells to cope with ER stress, leading to cell death.
